基本信息:
- 专利标题: 보다 높은 탄수화물 항원 밀도 및 신규한 사포닌 애쥬번트를 갖는 백신
- 专利标题(英):KR20180053599A - Vaccines with higher carbohydrate antigen density and novel saponin adjuvant
- 申请号:KR20177034329 申请日:2014-01-06
- 公开(公告)号:KR20180053599A 公开(公告)日:2018-05-23
- 发明人: LEE WEI HAN , WANG NAN HSUAN , CHANG CHUNG HAO , HSIEH YIH HUANG , WANG CHENG CHI , LIN YU HSIN , LIN YU CHEN , CHEN I JU , YU CHENG DER TONY
- 申请人: OBI PHARMA INC
- 专利权人: OBI PHARMA INC
- 当前专利权人: OBI PHARMA INC
- 优先权: US201361748880 2013-01-04
- 主分类号: A61K39/02
- IPC分类号: A61K39/02 ; A61K39/00 ; A61K39/39 ; C07H15/24
摘要:
본발명은담체단백질로서디프테리아독소 (DT)에컨쥬게이션된탄수화물항원을포함하는백신을제공하고, 여기서탄수화물항원분자의수 대담체단백질분자의수의비는 5:1 보다높다. 신규한사포닌애쥬번트및 본원에기재된유효량의백신을투여함에의해암 세포를억제하는방법이또한본원에기재된다.
摘要(英):
The present invention provides a vaccine comprising a carbohydrate antigen conjugated to diphtheria toxin (DT) as a carrier protein, wherein the ratio of the number of carbohydrate number of antigen molecules for the carrier protein molecule 5: higher than 1. The method of inhibiting cancer cells by administering the novel saponin as an adjuvant and an effective amount of a vaccine as described herein are also described herein.
信息查询:
EspacenetIPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K39/00 | 含有抗原或抗体的医药配制品 |
--------A61K39/02 | .细菌性抗原 |